Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gross Anatomy of the Liver01:17

Gross Anatomy of the Liver

The liver, the largest gland within the human body, is a firm and reddish-brown organ. This wedge-shaped structure weighs approximately 1.5 kg and occupies a significant portion of the right hypochondriac and epigastric regions. It extends more to the right of the body's midline than to the left.
Located under the diaphragm, the liver is almost entirely ensconced within the rib cage, providing it with substantial protection. Except for the superior most bare area, the liver's surface is covered...
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Flow-enhanced electrochemical aptamer sensor for nanomolar detection of NGAL in blood plasma for kidney injury diagnosis.

Biosensors & bioelectronics·2026
Same author

TGFβ activity stabilizes ACC1 to increase de novo lipogenesis in metabolic liver disease.

Molecular metabolism·2026
Same author

Autologous macrophage therapy increases transplant-free survival in cirrhosis: Long-term follow-up of a phase 2 clinical trial.

Cell stem cell·2026
Same author

IDH1 R132 mutations or HER2-positivity and benefit from platinum-based therapy for biliary tract cancers.

JHEP reports : innovation in hepatology·2026
Same author

Deciphering cytochrome P450 reductase role in MASLD: molecular mechanisms and pathophysiological implications.

Nature reviews. Gastroenterology & hepatology·2026
Same author

Phosphatidylethanol testing: patterns, demographic and clinical correlates, and outcomes.

Alcohol and alcoholism (Oxford, Oxfordshire)·2026
Same journal

Mapping of class II HLA restriction of SepSecS-specific CD4 T cell epitopes in autoimmune hepatitis.

JHEP reports : innovation in hepatology·2026
Same journal

A hepatocyte-derived GPNMB-RYK signaling axis in MASH progression.

JHEP reports : innovation in hepatology·2026
Same journal

Changes in alcohol use following a diagnosis of alcohol-related liver disease: a clinical cohort study.

JHEP reports : innovation in hepatology·2026
Same journal

Pre-liver transplant assessment of patients with acute-on-chronic liver failure: An international survey.

JHEP reports : innovation in hepatology·2026
Same journal

Reply to "Comparison of patients with HBV-related HCC with and without MASLD after liver transplantation".

JHEP reports : innovation in hepatology·2026
Same journal

Long-term antigen reduction does not achieve durable HBV control in mice but enhances therapeutic vaccine efficacy.

JHEP reports : innovation in hepatology·2026
See all related articles

Related Experiment Video

Updated: Jun 11, 2026

Isolation of Nuclei from Flash-Frozen Liver Tissue for Single-Cell Multiomics
09:09

Isolation of Nuclei from Flash-Frozen Liver Tissue for Single-Cell Multiomics

Published on: December 9, 2022

LiRNA: An Interactive Atlas of Human Liver RNAseq Databases.

Gloria Alvarez Sola1, Nirajan Shrestha1, Raquel Benede Ubieto1

  • 1Liver Center, Division of Gastroenterology, Massachusetts General Hospital, Boston, MA, USA; Endocrine Unit, Division of Endocrinology, Massachusetts General Hospital, Boston, MA, USA.

JHEP Reports : Innovation in Hepatology
|June 9, 2026
PubMed
Summary
This summary is machine-generated.

A new interactive atlas, LiRNA, integrates over 3,000 human liver RNA-seq datasets. This resource improves the validation of mouse findings in human liver disease research, revealing that less than half of recent translational findings generalize consistently.

Keywords:
AtlasFibrosisHuman liverMASHMASLDRNAseqTranscriptomics

More Related Videos

RNA Next-Generation Sequencing and a Bioinformatics Pipeline to Identify Expressed LINE-1s at the Locus-Specific Level
11:04

RNA Next-Generation Sequencing and a Bioinformatics Pipeline to Identify Expressed LINE-1s at the Locus-Specific Level

Published on: May 19, 2019

Related Experiment Videos

Last Updated: Jun 11, 2026

Isolation of Nuclei from Flash-Frozen Liver Tissue for Single-Cell Multiomics
09:09

Isolation of Nuclei from Flash-Frozen Liver Tissue for Single-Cell Multiomics

Published on: December 9, 2022

RNA Next-Generation Sequencing and a Bioinformatics Pipeline to Identify Expressed LINE-1s at the Locus-Specific Level
11:04

RNA Next-Generation Sequencing and a Bioinformatics Pipeline to Identify Expressed LINE-1s at the Locus-Specific Level

Published on: May 19, 2019

Area of Science:

  • Genomics
  • Bioinformatics
  • Translational Medicine

Background:

  • Mouse models are crucial for liver disease research, but their translational relevance to human disease is often debated.
  • Human transcriptomic data is increasingly used to validate mouse findings, but existing databases are fragmented and difficult to access.
  • There is a need for a unified, accessible resource for human liver RNA-sequencing data.

Purpose of the Study:

  • To create an interactive atlas of human liver RNA-sequencing datasets to overcome limitations of existing resources.
  • To facilitate the validation of translational findings from mouse models to human liver disease.
  • To improve the rigor and generalizability of liver disease research.

Main Methods:

  • Integrated 17 RNA-sequencing datasets from over 3,000 human liver biopsies into a unified web application (LiRNA).
  • Harmonized FASTQ processing, inferred biological sex, and genotyped key metabolic-associated fatty liver disease (MAFLD) variants.
  • Systematically evaluated the generalizability of 64 published gene-phenotype and gene-gene correlation findings.

Main Results:

  • LiRNA accurately recapitulates known hepatic biology, including fibrosis-associated transcripts and sexually dimorphic gene expression.
  • The platform captures genotype-specific transcriptional signatures and response signatures to Hepatitis C virus (HCV).
  • Fewer than half of the 64 assessed translational findings generalized consistently across independent, larger cohorts within LiRNA.

Conclusions:

  • LiRNA is an open-access, interactive platform integrating harmonized human liver RNA-sequencing data.
  • It enables contextualization of translational findings across diverse human populations and disease contexts.
  • LiRNA lowers computational barriers, enhancing the rigor and generalizability of liver disease research.